|
"hsiao cf"的相關文件
顯示項目 116-140 / 204 (共9頁) << < 1 2 3 4 5 6 7 8 9 > >> 每頁顯示[10|25|50]項目
國家衛生研究院 |
2011-08 |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer
|
Wang, SC;Ho, IK;Tsou, HH;Tian, JN;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Chen, CY;Liu, SC;Wu, HY;Chan, HW;Tsai, MH;Lin, PS;Liu, YL |
中國醫藥大學 |
2011-08 |
CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer
|
(Wang SC);(Ho IK);(Tsou HH);(Tian JN);(Hsiao CF);(Chen CH);(Tan HK);(Lin L);(Wu CS);(Su LW);黃介良(Chieh-Liang Huang);(Yang YH);(Liu ML);(Lin KM);(Chen CY);(Liu SC);(Wu HY);(Chan HW);(sai MH);(Lin PS);(Liu YL)* |
國家衛生研究院 |
2011-07 |
A consistency approach to evaluation of bridging studies and multiregional trials
|
Tsou, HH;Chien, TY;Liu, JP;Hsiao, CF |
國家衛生研究院 |
2011-06 |
Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers
|
Lo, YL;Hsiao, CF;Jou, YS;Chang, GC;Tsai, YH;Su, WC;Chen, KY;Chen, YM;Huang, MS;Hsieh, WS;Chen, CJ;Hsiung, CA |
國家衛生研究院 |
2011-05 |
Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine
|
Liu, YL;Lin, KM;Tsou, HH;Tian, JN;Chen, CH;Shen, WW;Lu, SC;Liu, CY;Hsiao, MC;Tang, HS;Liu, SI;Chang, LH;Hsiao, CF;Kuo, HW;Hsu, YT;Liu, SC;Tu, SL |
國家衛生研究院 |
2011-05 |
The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction
|
Tian, JN;Wang, SC;Chen, CH;Tsou, HH;Ho, IK;Chan, HW;Fang, CP;Hsiao, CF;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Wu, JY;Lin, KM;Chen, CY;Liu, SC;Liu, YL |
國家衛生研究院 |
2011-05 |
Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients
|
Tian, JN;Wang, SC;Ho, IK;Tsou, HH;Lin, KM;Hsiao, CF;Chen, CH;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, CY;Liu, SC;Wu, HY;Kuo, HW;Liu, YL |
國家衛生研究院 |
2011-03 |
An alternative phase II/III design for continuous endpoints
|
Huang, WS;Liu, JP;Hsiao, CF |
高雄醫學大學 |
2011 |
Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
|
黃明賢; Lo YL;Hsiao CF;Jou YS;Chang GC;Tsai YH;Su WC;Chen KY;Chen YM;Huang MS;Hsieh WS;Chen CJ;Hsiung CA |
國家衛生研究院 |
2010-12 |
Genetic variants of human urea transporter-2 are associated with metabolic syndrome in Asian population
|
Tsai, HJ;Hsiao, CF;Ho, LT;Chuang, LM;He, CT;Curb, JD;Quertermos, T;Hsiung, CA;Sheu, WH |
國家衛生研究院 |
2010-12 |
Bridging diversity: extrapolating foreign data to a new region
|
Chow, SC;Hsiao, CF |
國家衛生研究院 |
2010-11 |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Lin, KM;Tsou, HH;Tsai IJ;Hsiao, MC;Hsiao, CF;Liu CY;Shen, WW;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Kuo, HW;Liu, SC;Chan, HW;Hsu, YT;Tian, JN;Liu, YL |
國家衛生研究院 |
2010-11 |
Medical resources utilization of five most prevalent cancers in Taiwan (lung cancer, liver cancer, colorectal cancer, gastric cancer, and brest cancer): 2001 similar to 2007
|
Liu, JS;Chen, LT;Hsiao, CF |
國家衛生研究院 |
2010-08 |
ATM polymorphisms and risk of lung cancer among never smokers
|
Lo, YL;Hsiao, CF;Jou, YS;Chang, GC;Tsai, YH;Su, WC;Chen, YM;Huang, MS;Chen, HL;Yang, PC;Chen, CJ;Hsiung, CA |
國家衛生研究院 |
2010-08 |
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia
|
Hsiung, CA;Lan, Q;Hong, YC;Chen, CJ;Hosgood, HD;Chang, IS;Chatterjee, N;Brennan, P;Wu, C;Zheng, W;Chang, GC;Wu, T;Park, JY;Hsiao, CF;Kim, YH;Shen, H;Seow, A;Yeager, M;Tsai, YH;Kim, YT;Chow, WH;Guo, H;Wang, WC;Sung, SW;Hu, Z;Chen, KY;Kim, JH;Chen, Y;Huang, L;Lee, KM;Lo, YL;Gao, YT;Liu, L;Huang, MS;Jung, TH;Jin, G;Caporaso, N;Yu, D;Kim, CH;Su, WC;Shu, XO;Xu, P;Kim, IS;Chen, YM;Ma, H;Shen, M;Cha, SI;Tan, W;Chang, CH;Sung, JS;Zhang, M;Yang, TY;Park, KH;Yuenger, J;Wang, CL;Ryu, JS;Xiang, Y;Deng, Q;Hutchinson, A;Kim, JS;Cai, Q;Landi, MT;Yu, CJ;Tucker, M;Hung, JY;Lin, CC;Perng, RP;Boffetta, P;Chen, CY;Chen, KC;Yang, SY;Hu, CY;Chang, CK;Fraumeni, JF, Jr.;Chanock, S;Yang, PC;Rothman, N;Lin, D |
國家衛生研究院 |
2010-07 |
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective
|
Tsou, HH;Chow, SC;Lan, KK;Liu, JP;Wang, M;Chern, HD;Ho, LT;Hsiung, CA;Hsiao, CF |
國家衛生研究院 |
2010-07 |
Sample size determination for a specific region in a multiregional trial
|
Ko, FS;Tsou, HH;Liu, JP;Hsiao, CF |
國家衛生研究院 |
2010-01 |
Statistical test for evaluation of biosimilarity in variability of follow-on biologics
|
Hsieh, TC;Chow, SC;Liu, JP;Hsiao, CF;Chi, E |
國家衛生研究院 |
2009-09 |
Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: A case-control study in Taiwan
|
Chang, CH;Hsiao, CF;Chang, GC;Tsai, YH;Chen, YM;Huang, MS;Su, WC;Hsieh, WS;Yang, PC;Chen, CJ;Hsiung, CA |
國家衛生研究院 |
2009-06 |
Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients
|
Jou, YS;Lo, YL;Hsiao, CF;Chang, GC;Tsai, YH;Su, WC;Chen, YM;Huang, MS;Chen, HL;Chen, CJ;Yang, PC;Hsiung, CA |
國家衛生研究院 |
2009-06 |
Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine
|
Lo, YC;Lauderdale, TL;Chang, SY;Hsiao, CF;Hung, CC;Chang, SC |
國家衛生研究院 |
2009-03 |
Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells
|
Yang, YL;Wang, CW;Chen, CT;Wang, MH;Hsiao, CF;Lo, HJ |
國家衛生研究院 |
2009-01 |
A polymorphism in the APE1 gene promoter is associated with lung cancer risk
|
Lo, YL;Jou, YS;Hsiao, CF;Chang, GC;Tsai, YH;Su, WC;Chen, KY;Chen, YM;Huang, MS;Chi, YH;Chen, CJ;Hsiung, CA |
國家衛生研究院 |
2009-01 |
Statistical methods for evaluating the linearity in assay validation
|
Hsieh, E;Hsiao, CF;Liu, JP |
國家衛生研究院 |
2009 |
Statistical validation of traditional Chinese diagnostic procedures
|
Hsiao, CF;Tsou, HH;Pong, A;Liu, JP;Lin, CH;Chang, YJ;Chow, SC |
顯示項目 116-140 / 204 (共9頁) << < 1 2 3 4 5 6 7 8 9 > >> 每頁顯示[10|25|50]項目
|